Skip to main content
. 2019 Jun 10;11(6):269. doi: 10.3390/pharmaceutics11060269

Figure 4.

Figure 4

Particle surfaces of (a) mesoporous silica Syloid, (b) Felodipine raw material, (c) FELO-Syloid, (d) FELO-Syloid-hypromellose acetate succinate (HPMCAS), (e) Furosemide raw material, (f) FURO-Syloid, and (g) FURO-Syloid-HPMCAS. SEM images were taken for samples at a drug load of 300% surface coverage.